2015
DOI: 10.1016/j.phrs.2015.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
120
1
3

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 206 publications
(132 citation statements)
references
References 373 publications
(94 reference statements)
1
120
1
3
Order By: Relevance
“…Another biomarker, ellagic acid has gained much importance in the recent years due to its multiple pharmacological activities and molecular targets. It has shown several antibacterial, anticarcinogenic and antiatherogenic activities (Garcia-Nino and Zazueta, 2015). Several studies have enumerated the role of ellagic acid in effective lowering of plasma lipids, reduced oxidative stress, inhibition of apoptosis, scavengers of oxygen and hydroxyl radicals as well as inhibition of lipid peroxidation both in vitro and in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Another biomarker, ellagic acid has gained much importance in the recent years due to its multiple pharmacological activities and molecular targets. It has shown several antibacterial, anticarcinogenic and antiatherogenic activities (Garcia-Nino and Zazueta, 2015). Several studies have enumerated the role of ellagic acid in effective lowering of plasma lipids, reduced oxidative stress, inhibition of apoptosis, scavengers of oxygen and hydroxyl radicals as well as inhibition of lipid peroxidation both in vitro and in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Through the action of human colonic microflora, EA is partially converted into metabolites, including hydroxy-6H-benzopyran-6-one derivatives, primarily urolithin A (UA) [12]. Both, EA and urolithins enter the circulation.…”
Section: Introductionmentioning
confidence: 99%
“…It is also worth mentioning that ellagic acid has received special attention from researchers because of its pluripotent biological activity and the multiple molecular targets that it acts upon [102]. Based on this, an animal model of hepatocellular carcinoma demonstrated that the oral administration of ellagic acid (50 mg/ Kg/day), 7 days before and 14 days after tumour induction (N-nitrosodiethylamine and CCl 4 ), provided 23.6 % of inhibition of ARG activity when compared to the negative control group (healthy rats).…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, the amount of ellagitannins in systemic circulation and tissues is virtually undetectable, whereas urolithins and their conjugates can be found in higher levels (µM). It has been reported that ellagitannin metabolites can be detected in the liver and kidneys [106], urolithins are enhanced in the prostate, intestinal tissue, and colon in mice, and urolithin A-glucuronide is the main metabolite found in the human prostate (> 2 ng/g tissue) as well as traces of urolithin B-glucuronide and ellagic acid-dimethyl ether [102,107].…”
Section: Methodsmentioning
confidence: 99%